Summary In a prospective study of about 22,000 men attending a screening centre, serum samples were collected and stored. The concentration of vitamin E (alpha-tocopherol) was measured in the stored serum samples from 271 men subsequently notified as having cancer and from 533 unaffected controls, matched for age, smoking history and duration of storage of the serum samples. The mean vitamin E level of the cancer subjects was not significantly different from that of their matched controls. The mean level in the cancer subjects who were diagnosed as having cancer before the elapse of one year from the date of blood collection was, however, significantly lower than the mean concentration of their matched controls (10.0 and 11.5 mgl-l respectively, P=0.003). For subjects whose cancers were diagnosed one or more years after blood collection the difference was not statistically significant either for all cancers or for cancers of six sites considered separately, vi-. lung, colon and rectum, stomach, bladder, central nervous system and skin. The most likely explanation for these results is that the low vitamin E levels observed in these subjects were a metabolic consequence, rather than a precursor, of the cancer. This would explain, at least in part, the overall inverse association between serum vitamin E and risk of cancer observed in the published epidemiological studies on serum vitamin E and cancer.
Thcre is evidence to suggest that vitamin E (alpha-tocoway 533 matched controls were identified and tested, 9 less pherol) may play a role in reducing the incidence of cancer.
than the intended 542 because for 9 subjects serum from one Vitamin E is a powerful anti-oxidant, a free radical of the 2 controls was spoilt in transport prior to assay. The scavenger that inhibits lipid peroxidation (Burton et al., 1983;  vitamin E (alpha-tocopherol) estimations were performed by Burton & Ingold, 1981) . This process is important in high pressure liquid chromatography (Vuilleumier et al., maintaining the integrity of cell membranes (Diplock, 1983) .
1983). Samples were tested in four separate series, two in Vitamin E supplementation has been shown to reduce the 1981, one in 1983 and one in 1985. Sera from subjects and number and incidence of chemically induced tumours in their matched controls were always assayed in the same animals (Haber & Wissler, 1962; Harmon, 1969; Cook & McNamara, 1980) although some studies failed to show such are adjusted for series, to take account of any changes in an effect (Reddy & Tanaka, 1986; Toth & Patil, 1983 (Breslow & Day, 1980) .
The design of the prospective study has been described before (Wald et al., 1980 (Wald et al., , 1986 together. There was a statistically significant difference in Two controls were selected for each of the subjects, matched serum vitamin E levels between subjects whose cancers were on age (within 5 years), duration of storage of the serum diagnosed before the elapse of one year from the date of sample (within 3 months), smoking status (current smoker, blood collection and their matched controls (10.0 and ex-smoker or life-long non-smoker) and, for current 11.5 mg 1-is respectively, P = 0.003). For subjects whose smokers, smoking habits -type of product smoked cancers were diagnosed one or more years after blood (cigarette, cigar or pipe), amount smoked (within 5 cigarettes collection the difference was not statistically significant and per day, two cigars per day or an ounce of tobacco per for these 'late' cases there was no suggestion of a difference week) and age of starting to smoke (within 5 years). In this in vitamin E levels between subjects and controls for cancer on _n_r __(witin _____________i_t _______t_r cr at any of the specified sites (Table I) . Indeed, the subject-*PrcscIit address: Clinical Trial Scrvicc Unit, Raldcliffc Infilrmary, control differences in these 'late' cases and the 'early' ones Oxford, 0X2 6HE, UK. Table V Mean vitamin E concentrations (mg I1) in cancer subjects
The results of this study, together with those previously and controls according to duration of storage of the serum sample published on serum retinol and cancer (Wald et al., 1980) and those on serum cholesterol and cancer (Rose & pattern (or significant differences) (Table III) ; Table IV shows the mean vitamin E levels according to smoking category. Again, there was no clear pattern, though there was a suggestion that serum vitamin E levels were lower in though the cancer may not have been symptomatic or smokers than in non-smokers. Table V shows the mean clinically apparent when the blood sample was collected. vitamin E levels according to duration of storage of the This conclusion is supported by the fact that vitamin E levels serum sample. There was a general decline in vitamin E were similarly low in the 50 clinically prevalent cases (includ-concentration with increasing storage time; on average, the ing 23 skin cancers) at the time of blood collection and in concentration declined by 0.47mgl11 (or -5%) per year. the 40 cancers that were diagnosed afterwards but still within Therefore, matching for duration of storage was critical one year (including 8 skin cancers).
while matching for age or smoking habits was much less so. Our results suggest that it is unlikely that serum vitamin E Table VI summarises the prospective epidemiological in the concentrations naturally found in well nourished evidence on serum vitamin E and cancer. Two of the seven populations has any substantial effect on the risk of studied showed statistically significantly lower serum vitamin developing cancer. It follows that any cancer inhibitory effect E levels in subjects who developed cancer compared with suggested by the anti-oxidant activity of vitamin E or by controls who did not. Although the other five studies some of the animal experimental evidence is not apparent at individually did not show statistically significant differences, levels naturally found in man. four yielded differences in the same direction and one aStandard error (s.e.) was based on a vitamin E standard deviation of 1 .6mgl F' estimated from one published P value; bse was based on a vitamin E standard deviation of 4.0 mg1-' as found in the present study; cThe overall average across studies was calculated as an average of the individual mean differences, each weighted inversely according to its variance; NS =not statistically significant (P>0.05).
showed no difference at all. Taken as a whole, the seven studies show an inverse association between serum vitamin E and cancer, an association which is unlikely to be due to chance. Our own results suggest one explanation for this association, namely that the cancer caused the low vitamin E levels rather than the reverse. It is, however, probably not the only explanation. It is not, for example, a satisfactory explanation for the inverse association shown between plasma vitamin E and breast cancer in women reported by Wald et al., 1984 (a result which requires independent corroboration) because only 6 of 43 cases were diagnosed within 2 years of blood collection. The extent to which it can offer a full explanation for the results from the other studies cited in Table VI would rest on the outcome of a statistical analysis of the differences in vitamin E levels in cancer subjects and controls in these studies classified by time to diagnosis.
